"John Leung, MD is the founding physician and CEO of Boston Specialists/Boston Food Allergy Center. He a US-trained physician dual board-certified in Allergy/ Immunology and Gastroenterology. He has coauthored numerous peer-reviewed manuscripts, scientific abstracts, book chapters, and online tutorials. He is accepting new patients. He sees patients with seasonal allergy, asthma, eosinophilic esophagitis, EGID, food allergy, food intolerance, mast cell activation syndrome, and other general allergy and GI conditions. His office offers wide range of services, including patch testing, food intolerance testing, allergy testing, PFT, allergy shots, oral immunotherapy (OIT), immingration exams, etc. Visit our website for more information."

During the past decade, Boston Specialists conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Boston Specialists" are "Eosinophilic Esophagitis" (3 trials). Many other conditions were trialed in "Boston Specialists" in a lesser frequency.

Most popular intervention types in "Boston Specialists" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "APT-1011" (1 trials), "APT-1011 3 mg HS" (1 trials), "CC-93538" (1 trials), "Placebo" (1 trials) and "Placebo oral tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Boston Specialists" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Boston Specialists". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Boston Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Boston Specialists, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".